Goodness Growth Holdings Inc (GDNSF)
0.4764
-0.01
(-2.78%)
USD |
OTCM |
Jun 14, 16:00
Goodness Growth Holdings Max Drawdown (5Y): 97.93% for May 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
May 31, 2024 | 97.93% |
April 30, 2024 | 97.93% |
March 31, 2024 | 97.93% |
February 29, 2024 | 97.93% |
January 31, 2024 | 97.93% |
December 31, 2023 | 97.93% |
November 30, 2023 | 97.93% |
October 31, 2023 | 97.93% |
September 30, 2023 | 97.93% |
August 31, 2023 | 97.93% |
July 31, 2023 | 97.86% |
June 30, 2023 | 97.86% |
May 31, 2023 | 97.86% |
April 30, 2023 | 97.86% |
March 31, 2023 | 97.86% |
February 28, 2023 | 96.97% |
January 31, 2023 | 96.94% |
December 31, 2022 | 96.94% |
November 30, 2022 | 94.97% |
October 31, 2022 | 94.97% |
September 30, 2022 | 94.97% |
August 31, 2022 | 94.97% |
July 31, 2022 | 94.97% |
June 30, 2022 | 94.97% |
May 31, 2022 | 94.97% |
Date | Value |
---|---|
April 30, 2022 | 94.97% |
March 31, 2022 | 94.97% |
February 28, 2022 | 94.97% |
January 31, 2022 | 94.97% |
December 31, 2021 | 94.97% |
November 30, 2021 | 94.97% |
October 31, 2021 | 94.97% |
September 30, 2021 | 94.97% |
August 31, 2021 | 94.97% |
July 31, 2021 | 94.97% |
June 30, 2021 | 94.97% |
May 31, 2021 | 94.97% |
April 30, 2021 | 94.97% |
March 31, 2021 | 94.97% |
February 28, 2021 | 94.97% |
January 31, 2021 | 94.97% |
December 31, 2020 | 94.97% |
November 30, 2020 | 94.97% |
October 31, 2020 | 94.97% |
September 30, 2020 | 94.97% |
August 31, 2020 | 94.97% |
July 31, 2020 | 94.97% |
June 30, 2020 | 94.97% |
May 31, 2020 | 94.97% |
April 30, 2020 | 94.97% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
52.60%
Minimum
Jun 2019
97.93%
Maximum
Aug 2023
92.67%
Average
94.97%
Median
Mar 2020
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -46.57 |
Beta (5Y) | 1.213 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 105.0% |
Historical Sharpe Ratio (5Y) | -0.2853 |
Historical Sortino (5Y) | -0.5696 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 41.18% |